Embecta Corp

EMBC

Company Profile

  • Business description

    Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

  • Contact

    300 Kimball Drive
    Suite 300
    ParsippanyNJ07054
    USA

    T: +1 862 401-0000

    https://www.embecta.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    30 September 2027

    Employees

    1,850

Stocks News & Analysis

stocks

Two cheap wide moat ASX shares

These shares are trading at a discount to our fair value discount and have sustainable competitive advantages.
stocks

Anthropic: Are the shares undervalued given the IPO pricing range?

There may be meaningful upside as Anthropic is pricing its stock as a reflection of current sentiment, not the company’s fundamentals.
stocks

Valuation looks stretched for ASX healthcare share

Strong fundamentals meet a demanding valuation.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,274.206.400.07%
CAC 408,361.3628.490.34%
DAX 4026,771.88109.110.41%
Dow JONES (US)52,622.78136.290.26%
FTSE 10010,863.0927.620.25%
HKSE24,008.55307.37-1.26%
NASDAQ25,474.238.040.03%
Nikkei 22560,819.36359.780.60%
NZX 50 Index14,259.2391.820.65%
S&P 5007,629.219.830.13%
S&P/ASX 2009,146.8017.800.19%
SSE Composite Index3,655.8324.81-0.67%

Market Movers